How a Doctor Monitors Herself for Brain Tumors and the No. 1 Most Common Symptom
A neuro-oncologist at the Mayo Clinic reveals the telltale signs of a “classic brain tumor headache” and other brain tumor symptoms she looks for in her own body.
All Posts by
A neuro-oncologist at the Mayo Clinic reveals the telltale signs of a “classic brain tumor headache” and other brain tumor symptoms she looks for in her own body.
Sylvester Comprehensive Cancer Center researchers received a $2.7 million grant to study stress management in breast cancer survivorship.
Derek had his prostate cancer treatment at UHealth SoLé Mia where Sylvester brings its most innovative therapies and state-of-the-art technology to patients.
Researchers from Florida’s leading cancer centers gathered for the 2026 Florida Academic Cancer Center retreat on May 7-8 in Tampa. Photos by Nicholas Gould By Pat Carragher Key Takeaways: Florida’s four NCI-designated cancer centers met in Tampa to expand statewide cancer research collaboration Florida Academic Cancer…
New research points to DNA methylation as a key factor in predicting who may respond to treatment and a potential new way to target resistant tumors.
Researchers at Moffitt Cancer Center have played a key role in bringing new therapies from clinical trials to patients.
The UF Health Cancer Institute hosted the spring 2026 Florida Cancer Control and Research Advisory Council meeting.
A new drug targeting triple-negative breast cancer overwhelms cancer cells with fat-like molecules called ceramides.
Sylvester is launching a 12-week lifestyle medicine program to support safe weight loss for cancer survivors.
Rosa Rademakers, Ph.D., a neurogeneticist whose work at Mayo Clinic led to a landmark finding in neurodegenerative disease, has been awarded the 2026 Breakthrough Prize in Life Sciences for the discovery of the most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which charted the path for new mechanistic studies of these diseases.